» Articles » PMID: 31002893

GLP-1: Molecular Mechanisms and Outcomes of a Complex Signaling System

Overview
Journal Neurochem Int
Specialties Chemistry
Neurology
Date 2019 Apr 20
PMID 31002893
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Meal ingestion provokes the release of hormones and transmitters, which in turn regulate energy homeostasis and feeding behavior. One such hormone, glucagon-like peptide-1 (GLP-1), has received significant attention in the treatment of obesity and diabetes due to its potent incretin effect. In addition to the peripheral actions of GLP-1, this hormone is able to alter behavior through the modulation of multiple neural circuits. Recent work that focused on elucidating the mechanisms and outcomes of GLP-1 neuromodulation led to the discovery of an impressive array of GLP-1 actions. Here, we summarize the many levels at which the GLP-1 signal adapts to different systems, with the goal being to provide a background against which to guide future research.

Citing Articles

Advances in GLP-1 receptor agonists for pain treatment and their future potential.

He Y, Xu B, Zhang M, Chen D, Wu S, Gao J J Headache Pain. 2025; 26(1):46.

PMID: 40016636 PMC: 11869436. DOI: 10.1186/s10194-025-01979-4.


Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females?.

Krivoshein G, Rivera-Mancilla E, MaassenVanDenBrink A, Giniatullin R, van den Maagdenberg A J Headache Pain. 2025; 26(1):40.

PMID: 39994546 PMC: 11853570. DOI: 10.1186/s10194-025-01966-9.


Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.

Ayoub M, Chela H, Amin N, Hunter R, Anwar J, Tahan V J Clin Med. 2025; 14(3).

PMID: 39941615 PMC: 11818918. DOI: 10.3390/jcm14030944.


Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential.

Al-Noshokaty T, Abdelhamid R, Abdelmaksoud N, Khaled A, Hossam M, Ahmed R Toxicol Rep. 2025; 14:101895.

PMID: 39911322 PMC: 11795145. DOI: 10.1016/j.toxrep.2025.101895.


Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central Amygdala.

Duran M, Willis J, Dalvi N, Fokakis Z, Virkus S, Hardaway J Endocrinology. 2025; 166(3).

PMID: 39888375 PMC: 11850305. DOI: 10.1210/endocr/bqaf019.


References
1.
Wootten D, Simms J, Miller L, Christopoulos A, Sexton P . Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations. Proc Natl Acad Sci U S A. 2013; 110(13):5211-6. PMC: 3612682. DOI: 10.1073/pnas.1221585110. View

2.
Hanski C, Huhle T, Gossrau R, REUTTER W . Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp Cell Res. 1988; 178(1):64-72. DOI: 10.1016/0014-4827(88)90378-3. View

3.
Furness S, Christopoulos A, Sexton P, Wootten D . Differential engagement of polar networks in the glucagon-like peptide 1 receptor by endogenous variants of the glucagon-like peptide 1. Biochem Pharmacol. 2018; 156:223-240. DOI: 10.1016/j.bcp.2018.08.033. View

4.
Hoosein N, GURD R . Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett. 1984; 178(1):83-6. DOI: 10.1016/0014-5793(84)81245-4. View

5.
Graham D, Erreger K, Galli A, Stanwood G . GLP-1 analog attenuates cocaine reward. Mol Psychiatry. 2012; 18(9):961-2. PMC: 3700649. DOI: 10.1038/mp.2012.141. View